CNS10-NPC-GDNF

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05306457 (ClinicalTrials.gov)	May 8, 2022	21/12/2021	CNS10-NPC-GDNF Delivered to the Motor Cortex for ALS	Human Neural Progenitor Cells Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) ...	Amyotrophic Lateral Sclerosis	Biological: CNS10-NPC-GDNF	Cedars-Sinai Medical Center	California Institute for Regenerative Medicine (CIRM)	Recruiting	18 Years	N/A	All	16	Phase 1	United States
2	NCT02943850 (ClinicalTrials.gov)	April 1, 2017	20/10/2016	CNS10-NPC-GDNF for the Treatment of ALS	Human Neural Progenitor Cells Secreting Glial Cell Line-Derived Neurotrophic Factor (CNS10-NPC-GDNF) ...	Amyotrophic Lateral Sclerosis	Biological: Stem cell (HPC) implantation;Device: Stereotactic surgical device	Cedars-Sinai Medical Center	California Institute for Regenerative Medicine (CIRM)	Completed	18 Years	N/A	All	18	Phase 1	United States

First Previous1Next Last